Q&A: ARUP Labs' Karl Voelkerding Discusses Bringing Next-Gen Sequencing to the Clinical Setting
March 30, 2010
Q&A: ARUP Labs' Karl Voelkerding Discusses Bringing Next-Gen Sequencing to the Clinical Setting
Karl Voelkerding, a clinician who has been evaluating next-generation sequencing technologies for use in diagnostics, is developing a sequencing-based genetic test for hypertrophic cardiomyopathy.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- In Sequence Annual Survey: Illumina Leads Market but Most Users Believe PacBio Will Provide Next Big Leap
January 25, 2011 / In Sequence - New Sequencing Platforms Drive Choice, Competition, Lawsuits in 2010
January 4, 2011 / In Sequence - TCGA Study Provides 'Roadmap' for Targeted Therapy, Genomic Subtyping in Ovarian Cancer
June 29, 2011 / Clinical Sequencing News - Next-Gen Sequencing Helps Uncover Cause of TB Outbreak, Piece Together Transmission Patterns
March 1, 2011 / In Sequence - Q&A: Syngenta's Erik Legg on Why Next-Gen Sequencing Is 'Beyond a Trend' in the Ag-bio Industry
November 30, 2010 / In Sequence